生物医药系列产品
数据
资源
版本对比
免费注册
预约演示
免费注册
Novadoz Has a Fast Start to 2021 with Generic Launches of
Albendazole
,
Droxidopa
,
Deferasirox
Granules, and
Pregabalin
ER
2021-04-23
·
BioSpace
仿制药
PISCATAWAY, N.J., April 23, 2021 /PRNewswire/ --
MSN Labs
, based in Hyderabad, India, received FDA approval to market their generic versions of
Albendazole
200mg tablets (AB rated to Albenza©),
Droxidopa
100mg, 200mg, 300mg capsules (AB rated to Northera ©),
Deferasirox
Granules 180mg, 360mg sachets (AB rated to Jadenu Sprinkles©) and
Pregabalin
ER 82.5mg, 165mg, 330mg tablets, (AB rated to Lyrica CR©) under the Novadoz label. Novadoz is the U.S sales and marketing affiliate for MSN's portfolio of finished dosage forms. The company has commenced shipping of all the products which received approvals during Q1 2021.
Albendazole
200mg is marketed in bottles of 2 tablets. It is indicated for the treatment of
neurocysticercosis
which is an
infection
caused by the pork tapeworm in the muscles, brain, and eyes that may cause
seizures
,
brain swelling
, and
vision problems
. The most recent 12 month published sales of the brand and generics total $26.9mil.
Droxidopa
100mg, 200mg, & 300mg are available in bottles of 30 capsules. It is indicated for the symptomatic treatment of
dizziness
,
lightheadedness
, or fainting/black out sensation due to
neurogenic orthostatic hypotension
(a sudden fall in blood pressure). Novadoz participated in a Day 1 launch of the product, coinciding with the expiration of the brand exclusivity. Previous 12 month published sales for the brand totaled $366mil. Novadoz has also offered a patient e-voucher assistance plan for those qualified consumers needing aid to cover their out of pocket prescription co-pay costs for
Droxidopa
. Visit NovadozPharma.com to learn more information on the program. Among their recent FDA approvals include niche products,
Deferasirox
Granules 180mg, and 360mg that are available in a carton of 30 sachets. The product is used treat ongoing high levels of iron in the body caused by multiple blood transfusions. It is also used to treat high levels of iron in people with a certain
blood disorder
who do not require blood transfusions. The other niche offering includes
Pregabalin ER
82.5mg, 165mg, and 330mg tablets available in bottles of 30. The product is indicated for the treatment of
pain
caused by nerve damage due to
diabetes
or
shingles
(
herpes zoster
). Seshu Akula, Novadoz President North
America Generics
, states, "The first quarter of 2021 was a very active period for the MSN/Novadoz organization with four FDA approvals. We successfully introduced these products to the market, while keeping pace with the high demand for our existing product line created by the pandemic." He adds, "MSN's position as a global leader in APIs has provided Novadoz with the scale and leveraged strength comparable to some of the largest generic pharma companies in the U.S. We are well positioned in the generic industry with a deep pipeline of oral solids, injectable, and specialty products that we expect to launch over the next 10 years."
MSN Labs
is engaged in the development and manufacturing of API (active pharmaceutical ingredients), KSMs (key starting materials), and product intermediates.
MSN
is a global leader in this category. Additionally, the company also manufactures oral solids, liquids, and specialty injectable products in sixty-five markets throughout the world, doing business in the U.S. as
Novadoz Pharmaceuticals
. For more information, visit the company's websites at NovadozPharma.com & MSNLabs.com. CONTACT: Tom DeStefano
Novadoz Pharmaceuticals
Vice President Sales and Marketing (848) 200-1909
机构
American Generics, Inc.
Novartis Pharmaceuticals KK
MSN Laboratories Pvt Ltd.
适应症
神经系统囊虫病
感染
癫痫发作
[+9]
靶点
-
药物
阿苯达唑
屈昔多巴
地拉罗司
[+1]
标准版
¥
16800
元/账号/年
新药情报库 | 省钱又好用!
立即使用
来和芽仔聊天吧
热门报告
特应性皮炎深度解析:药物开发、专利分析与风险评估
智慧芽生物医药
2024年7月全球首批及特殊审评药物报告
智慧芽生物医药
GPRC5D靶点专利调研报告
智慧芽生物医药
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
开始免费试用
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。
试用数据服务